Related Experiment Video
Updated: Jun 20, 2026
08:22
Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model
Published on: June 20, 2025
CNS immune responses following experimental stroke.
Dannielle Zierath1, Matthew Thullbery, Jessica Hadwin
1Department of Neurology, University of Washington School of Medicine, Harborview Medical Center, Box 359775 HMC, 325 9th Ave, Seattle, WA 98104-2499, USA.
Neurocritical Care
|August 29, 2009
Summary
Lipopolysaccharide (LPS) exposure during stroke increases the risk of detrimental autoimmune responses to brain antigens like myelin basic protein (MBP). Other inflammatory stimuli did not show this effect, highlighting LPS as a key factor.
Area of Science:
- Neuroimmunology
- Stroke research
- Autoimmunity
Background:
- Inflammatory insults during stroke can trigger autoimmune responses.
- Myelin basic protein (MBP) is a known target of detrimental autoimmunity post-stroke.
Purpose of the Study:
- To investigate if inflammatory stimuli beyond LPS induce central nervous system (CNS) autoimmunity.
- To determine if CNS autoimmunity targets antigens other than MBP.
Main Methods:
- Rats underwent middle cerebral artery occlusion (MCAO) and received LPS, staphylococcal enterotoxin B (SEB), lipoteichoic acid (LTA), or saline.
- Immune responses to MBP, neuron-specific enolase (NSE), and proteolipid protein (PLP) were analyzed post-stroke.
Main Results:
- SEB induced broad lymphocyte reactivity; LPS most strongly promoted a TH1(+) response.
- TH1(+) responses to MBP, NSE, or PLP correlated with worse outcomes, with NSE being most predictive.
- Cell-mediated autoimmunity to MBP or NSE was accompanied by humoral responses to these antigens.
Conclusions:
- Lipopolysaccharide (LPS), unlike SEB or LTA, significantly increases the risk of detrimental autoimmune responses.
- The study identifies a range of brain antigens targeted in LPS-induced CNS autoimmunity.
